Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lipoprotein-associated phospholipase A(2), a marker of vascular inflammation and systemic vulnerability.

× No keyword cloud information.

9 in total

1. Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells.

Authors: Rui Chen; Erin Brady; Thomas M McIntyre
Journal: J Immunol Date: 2011-02-02 Impact factor: 5.422

2. Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.

Authors: Alexander K Tsai; Brian T Steffen; Jose M Ordovas; Robert Straka; Xia Zhou; Naomi Q Hanson; Donna Arnett; Michael Y Tsai
Journal: Transl Res Date: 2011-02-26 Impact factor: 7.012

3. Cardiovascular Disease Risk Assessment: Review of Established and Newer Modalities.

Authors: David M Tehrani; Nathan D Wong
Journal: Curr Treat Options Cardiovasc Med Date: 2015-12

4. Coronary heart disease and genetic variants with low phospholipase A2 activity.

Authors: Linda M Polfus; Richard A Gibbs; Eric Boerwinkle
Journal: N Engl J Med Date: 2015-01-15 Impact factor: 91.245

Review 5. Lipoprotein-associated phospholipase A2: The story continues.

Authors: Fubao Huang; Kai Wang; Jianhua Shen
Journal: Med Res Rev Date: 2019-05-29 Impact factor: 12.944

6. STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A2 (Lp-PLA2) as a biomarker or risk factor for cardiovascular diseases.

Authors: Mohamed Hassan
Journal: Glob Cardiol Sci Pract Date: 2015-01-26

7. Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.

Authors: Si-Lin Lv; Zi-Fan Zeng; Wen-Qiang Gan; Wei-Qi Wang; Tie-Gang Li; Yu-Fang Hou; Zheng Yan; Ri-Xin Zhang; Min Yang
Journal: Acta Pharmacol Sin Date: 2021-07-05 Impact factor: 6.150

8. Val279Phe variant of Lp-PLA2 is a risk factor for a subpopulation of Indonesia patients with acute myocardial infarction.

Authors: Miryanti Cahyaningtias; Mohammad Saifur Rohman; Andi Wahjono Adi; Rina Yuda; Yanna Indrayana; Jayarani Fatimah Putri; Mifetika Lukitasari; Dadang Hendrawan
Journal: Genes Dis Date: 2016-09-17

9. On the present and future role of Lp-PLA₂ in atherosclerosis-related cardiovascular risk prediction and management.

Authors: Zlatko Fras; Jure Tršan; Maciej Banach
Journal: Arch Med Sci Date: 2020-08-20 Impact factor: 3.318

9 in total